[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/main/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_34 

# __manufacturers__

## This Stakeholder is identified by the following QID

* [Q42855995](https://github.com/mm80843/T3.5/blob/main/docs//Qid/Q42855995.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Improved supply chain efficiency](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_37.md)

## Risk affecting this stakeholder

* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_10.md)
* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1130.md)
* [Poor solubility and processing of graphene materials](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1133.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1135.md)
* [Risk of ineffective anti-SARS-CoV-2 coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1179.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1400.md)
* [Lack of standardized tests and protocols for UVGI efficacy and testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1758.md)

## Risks that can be mitigated by this stakeholder

* [Supply chain disruptions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_10.md)
* [Lack of interoperability](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_901.md)
* [Disruption of supply chains](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1130.md)
* [Lack of effective disinfectants](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1132.md)
* [Toxicity of nanomaterials](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1134.md)
* [Scalability and cost of graphene-based coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1135.md)
* [Risk of low viability period of SARS-CoV-2 on solids](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1178.md)
* [Risk of ineffective anti-SARS-CoV-2 coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1179.md)
* [Risk of adverse effects from anti-SARS-CoV-2 coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1180.md)
* [Risk of resistance development to anti-SARS-CoV-2 coatings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1181.md)
* [Inefficient negative air ionization](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1364.md)
* [Inadequate mixing of room air](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1365.md)
* [Supply chain disruption](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1400.md)
* [Shortage of personal protective equipment (PPE)](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1497.md)
* [Lack of standardized tests and protocols for UVGI efficacy and testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1758.md)
* [Lack of protective equipment](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1981.md)
* [Lack of personal protective equipment](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2078.md)
* [Limited access to personal protective equipment (PPE)](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2124.md)
* [Shortages of Personal Protective Equipment (PPE)](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2396.md)
* [Safety concerns with 3D-printed PPE](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2397.md)
* [Noise and inconvenience of personal air-purifying shields](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2399.md)
* [Inconvenience and cost of mask filters in smart face masks](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2400.md)
* [Lack of airtightness and safety concerns with reusable face shields](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2401.md)
* [Challenges in ventilator production](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2404.md)
* [Safety concerns with alternative ventilator designs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2405.md)

## This Stakeholder belongs to this StakeholderGroup

* [Private Sector](https://github.com/mm80843/T3.5/blob/main/docs/StakeholderGroup/PBN__StakeholderGroup_5.md)

## This Stakeholder belongs to this StakeholderSubgroup

* [Manufacturing and Industry](https://github.com/mm80843/T3.5/blob/main/docs/StakeholderSubgroup/PBN__StakeholderSubgroup_62.md)

